February 28, 2017

Morning Top News: The Western Union Company (NYSE:WU), Endologix, Inc. (NASDAQ:ELGX)

The Western Union Company (NYSE:WU) shares slumped -0.20% to $20.13 on Monday. Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against The The Western Union Company (NYSE:WU). Investors, who purchased or otherwise acquired Western Union securities on the open market between February 24, 2012 and January 19, 2017, both dates inclusive (the “Class Period”), are advised to contact the firm prior to the March 27, 2017 lead plaintiff deadline. No class has been certified in the above action yet. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member. On January 19, 2017, the U.S. Department of Justice and the Federal Trade Commission disclosed that Western Union admitted to “aiding and abetting wire fraud” by allowing illicit money transfers to benefit human traffickers, money laundering schemes, and otherwise enable the transfer of “dirty money.”

Technical Stock Analysis

Shares outstanding are recorded as 483.60 and total shares floated are 483.47. Company’s distance from 20 day simple moving average is 1.72% and distance from 50-Day simple moving average is -3.66%.

Best time to invest in stock market is when things are on odd side, and it’s not easy how to pick stocks. By reviewing stock prices from the stock market history of the company and examining its analysts ratings can give an investment picture with updated information of stock which helps investors to make investing decision. Stock has got OUTPERFORM rating from 1 analyst of Thomson Reuters, 13 analysts given HOLD rating to the stock and 3 given UNDERPERFORM rating. Analyst’s mean target price for WU is $19.31 while analysts mean recommendation is 3.20.

The Western Union Company (NYSE:WU) yearly performance is 12.60% and net profit margin is 4.70%. Annual EPS Growth of past 5 years is -22.50%. Company price to earnings (P/E) ratio, which measures the relationship between the earnings of a company and its stock price, is calculated as 40.75. The current share price indicate that stock is -11.32% away from its one year high and is moving 15.35% ahead of its 52-week low.

Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Endologix, Inc. (NASDAQ:ELGX) concerning possible violations of federal securities laws. Investors, who purchased or otherwise acquired Endologix shares between August 2, 2016 and November 16, 2016 inclusive (the “Class Period”), are encouraged to contact the firm prior to March 6, 2017, also known as the lead plaintiff motion deadline. Nellix is Endologix’s endovascular aneurysm sealing system used against infrarenal abdominal aortic aneurysms. Endologix allowed the Nellix system to be applied in the Nellix investigational device exemption (IDE) clinical trial, the EVAS FORWARD-IDE Study. However, Endologix revealed that the FDA asked for a follow-up on patients in the EVAS-FORWARD-IDE study to measure Nellix.

On 27 February 2017, Endologix, Inc. (NASDAQ:ELGX) shares moved to $6.69 after starting the day at $6.41. Stock has got OUTPERFORM rating from 1 analyst of Thomson Reuters, 6 analysts given HOLD rating to the stock and 0 given UNDERPERFORM rating. Analyst’s mean target price for ELGX is $8.23 while analysts mean recommendation is 2.20.

Leave a Reply

Your email address will not be published. Required fields are marked *